Armonica Technologies is an early stage medtech company developing its proprietary long-read sequencing platform for precision medicine applications. Armonica’s approach employs nanochannels to deliver single nucleic acid molecules through nanopores for optical readout by Raman spectroscopy, enabling direct reading of characteristic nucleotide and epigenetic signatures.